ARCHIVES

Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease

This article is from The Cancer Letter archive.

Vol. 35 No. 11 | November 30, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI Recieves Two Proposals For Antineoplaston Trials, None For Children; Stubble Elected To NAS

June 19, 1992

Mass. Law Requires Reimbursement For Off-Label Cancer Drugs

January 22, 1993

ONS Opposes AMA On “Registered Care Technologist”

August 19, 1988

In Brief: HHS Implements Debarment Regulations; Joftes, Cain Head New NCI contract, Grants Branches

October 24, 1980

NeoPharm To Begin Phase III Trial For Glioblastoma

December 26, 2003

NCI To Proceed With Its Training Program Without Waiting For Implementation of Research Service Act

September 20, 1974